These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interactions between pulmonary surfactant and alveolar macrophages in the pathogenesis of lung disease. Yoshida M; Whitsett JA Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL639-48. PubMed ID: 15579257 [TBL] [Abstract][Full Text] [Related]
8. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis. Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153 [No Abstract] [Full Text] [Related]
9. Therapy options in pulmonary alveolar proteinosis. Luisetti M; Kadija Z; Mariani F; Rodi G; Campo I; Trapnell BC Ther Adv Respir Dis; 2010 Aug; 4(4):239-48. PubMed ID: 20647242 [TBL] [Abstract][Full Text] [Related]
10. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis]. Rodríguez Portal JA; Rodríguez Becerra E; Sánchez Garrido A Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115 [TBL] [Abstract][Full Text] [Related]
11. Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. Sakagami T; Uchida K; Suzuki T; Carey BC; Wood RE; Wert SE; Whitsett JA; Trapnell BC; Luisetti M N Engl J Med; 2009 Dec; 361(27):2679-81. PubMed ID: 20042763 [No Abstract] [Full Text] [Related]
12. Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies. Luisetti M; Bruno P; Kadija Z; Suzuki T; Raffa S; Torrisi MR; Campo I; Mariani F; Pozzi E; Trapnell BC; Mariotta S Respir Care; 2011 Oct; 56(10):1608-10. PubMed ID: 21513605 [TBL] [Abstract][Full Text] [Related]
13. Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis. Martinez-Moczygemba M; Huston DP Curr Allergy Asthma Rep; 2010 Sep; 10(5):320-5. PubMed ID: 20623372 [TBL] [Abstract][Full Text] [Related]
14. [pulmonary alveolar proteinosis and anti-GM-CSF antibody]. Watanabe M; Nakata K Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1042-7. PubMed ID: 16846053 [No Abstract] [Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis. Reed JA; Whitsett JA Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report. Tazawa R; Nakata K; Inoue Y; Nukiwa T Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274 [TBL] [Abstract][Full Text] [Related]
17. Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung? Nakata K; Kanazawa H; Watanabe M Respirology; 2006 Jan; 11 Suppl():S65-9. PubMed ID: 16423275 [TBL] [Abstract][Full Text] [Related]
18. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor. Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary alveolar proteinosis. What is the role of GM-CSF in disease pathogenesis and treatment? Seymour JF; Presneill JJ Treat Respir Med; 2004; 3(4):229-34. PubMed ID: 15350161 [No Abstract] [Full Text] [Related]
20. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis]. Xu KF; Chen Y; Guo ZJ; Zhu YJ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]